The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1B study of SNX-5422 plus carboplatin (C) and paclitaxel (P) in patients with advanced non-small-cell lung cancer (NSCLC).
 
Martin Gutierrez
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Bayer; Karyopharm Therapeutics; Lilly
Speakers' Bureau - Bristol-Myers Squibb; Foundation One Inc; Merck
Research Funding - Abbvie (Inst); Acceleron Pharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); EMD Serono (Inst); Esanex (Inst); Gilead Sciences (Inst); Incyte (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Rexahn Pharmaceuticals (Inst); TG Therapeutics (Inst)
 
Giuseppe Giaccone
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Celgene; G1 Therapeutics; Inivata
Research Funding - AstraZeneca; Karyopharm Therapeutics; Lilly
 
Stephen V. Liu
Consulting or Advisory Role - ARIAD; Boehringer Ingelheim; Celgene; Genentech; Lilly; Pfizer
Research Funding - Bayer; Clovis Oncology; Corvus Pharmaceuticals; Esanex; Genentech/Roche; Ignyta; MedImmune; Merck; OncoMed; Pfizer; Threshold Pharmaceuticals
 
Zhonglin Hao
Consulting or Advisory Role - Pfizer
 
Christie Hilton
No Relationships to Disclose
 
James M Hinson
Stock and Other Ownership Interests - Aetna; HCA Healthcare; Johnson & Johnson; Merck
Consulting or Advisory Role - Biorestorative; Cytomedix; Dignify Therapeutics; Esanex; Inc Research; Neurocrine Biosciences; Viventia Biotech
Travel, Accommodations, Expenses - Cytomedix; Esanex; Neurocrine Biosciences; Viventia Biotech
 
Everardus Otto Orlemans
Employment - Esanex
Leadership - Esanex
Stock and Other Ownership Interests - Esanex
Patents, Royalties, Other Intellectual Property - Esanex
 
Alexander E. Drilon
Honoraria - AstraZeneca; Blueprint Medicines; Exelixis; Genentech/Roche; Ignyta; Loxo
Consulting or Advisory Role - ARIAD
Research Funding - Foundation Medicine